Alcon AG is a Switzerland-based eye care company. The Company research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Companyâs Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Companyâs Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The Company operates in 60 countries and serves consumers and patients in over 140 countries.
äŒæ¥ã³ãŒãALC
äŒç€ŸåAlcon AG
äžå Žæ¥Apr 09, 2019
æé«çµå¶è²¬ä»»è
ãCEOãEndicott (David J)
åŸæ¥å¡æ°25599
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Apr 09
æ¬ç€Ÿæåšå°Rue Louis d'Affry 6
éœåžFRIBOURG
蚌åžååŒæNASDAQ OMX NASDAQ Basic NYSE
åœSwitzerland
éµäŸ¿çªå·1700
é»è©±çªå·41589113800
ãŠã§ããµã€ãhttps://www.alcon.ch/
äŒæ¥ã³ãŒãALC
äžå Žæ¥Apr 09, 2019
æé«çµå¶è²¬ä»»è
ãCEOãEndicott (David J)
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
400.00M
ç±³ãã«ã§ããã
ALC.NB Final Cash Dividend of gross CHF 0.28 paid on May 07, 2026 going ex on May 06, 2026
ALC.NB Final Cash Dividend of gross CHF 0.2 paid on May 05, 2022 going ex on Apr 29, 2022
ALC.NB Final Cash Dividend of gross CHF 0.1 paid on May 06, 2021 going ex on May 04, 2021